Effects of a novel hepatitis B anti-viral drug E-CFCP in renal organic acid transporters

Effects of a novel hepatitis B anti-viral drug E-CFCP in renal organic acid transporters

Currently, the emergence of drug resistance is an important issue in the treatment of hepatitis B virus (HBV). Recently, our collaborating group developed a novel long-acting anti-HBV drug, E-CFCP. However, until this study, the effects of E-CFCP in the kidney have remained unclarified. Using cell v...

Full description

Bibliographic Details
Main Authors: Misaki Ishibane, Hirofumi Hashimoto, Meika Kaneko, Shota Saito, Sangjon Pae, Shinpei Saito, Yoshie Reien, Yuri Hirayama, Nobuyo Higashi-Kuwata, Hiroaki Mitsuya, Naohiko Anzai
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Journal of Pharmacological Sciences
Subjects:
Kidney damage
Nucleoside reverse transcriptase inhibitors
Renal tubular cells
Online Access:http://www.sciencedirect.com/science/article/pii/S134786132200069X

Internet

http://www.sciencedirect.com/science/article/pii/S134786132200069X

Similar Items